Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blanchet

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
A trial of dextromethorphan in parkinsonian patients with motor response complicationsL Verhagen Metman, P J Blanchet, P van den Munckhof, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 25, 2026
The role of dentists in the recognition of neurodegenerative and systemic conditions with neurological involvementAlberto Herrero Babiloni, Cibele Dal Fabbro, Firoozeh Samin, et al.
Neuroscience|August 10, 2017
Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugsCatherine Lévesque, Giovanni Hernandez, Souha Mahmoudi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 21, 2002
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatmentFrédéric Calon, Marc Morissette, Othman Ghribi, et al.
Brain Research|May 22, 1995
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complexF Calon, M Goulet, P J Blanchet, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 11, 2020
Parkinsonian Symptoms, Not Dyskinesia, Negatively Affect Active Life Participation of Dyskinetic Patients with Parkinson's DiseaseEtienne Goubault, Sarah Bogard, Pierre J Blanchet, et al.
Advances in Neurology|September 14, 2001
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate modelP J Blanchet, F Calon, M Morissette, et al.
Frontiers in Psychiatry|June 1, 2016
The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive BehaviorsSimon Morand-Beaulieu, Kieron P O'Connor, Maxime Richard, et al.
Journal of Clinical and Experimental Neuropsychology|May 31, 2026
Inhibition, motor dexterity, and non-verbal memory in Gilles de la Tourette syndrome: the impact of anxiety and depressionHouda Soubata, Emmanuelle Mazur-Lainé, Julie B Leclerc, et al.
Clinical Neuropharmacology|December 9, 1998
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's diseaseP J Blanchet, J Fang, M Gillespie, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
A trial of dextromethorphan in parkinsonian patients with motor response complicationsL Verhagen Metman, P J Blanchet, P van den Munckhof, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|February 25, 2026
The role of dentists in the recognition of neurodegenerative and systemic conditions with neurological involvementAlberto Herrero Babiloni, Cibele Dal Fabbro, Firoozeh Samin, et al.
Neuroscience|August 10, 2017
Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugsCatherine Lévesque, Giovanni Hernandez, Souha Mahmoudi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 21, 2002
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatmentFrédéric Calon, Marc Morissette, Othman Ghribi, et al.
Brain Research|May 22, 1995
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complexF Calon, M Goulet, P J Blanchet, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 11, 2020
Parkinsonian Symptoms, Not Dyskinesia, Negatively Affect Active Life Participation of Dyskinetic Patients with Parkinson's DiseaseEtienne Goubault, Sarah Bogard, Pierre J Blanchet, et al.
Advances in Neurology|September 14, 2001
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate modelP J Blanchet, F Calon, M Morissette, et al.
Frontiers in Psychiatry|June 1, 2016
The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive BehaviorsSimon Morand-Beaulieu, Kieron P O'Connor, Maxime Richard, et al.
Journal of Clinical and Experimental Neuropsychology|May 31, 2026
Inhibition, motor dexterity, and non-verbal memory in Gilles de la Tourette syndrome: the impact of anxiety and depressionHouda Soubata, Emmanuelle Mazur-Lainé, Julie B Leclerc, et al.
Clinical Neuropharmacology|December 9, 1998
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's diseaseP J Blanchet, J Fang, M Gillespie, et al.
Pageof 11